Search research articles
Contact Us
Filters
Showing results (31-40 of 401) with videos related to
Page
of 41
Sort By:
Expert Review of Cardiovascular Therapy
|
October 21, 2024
Antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary intervention
Mark Anthony Sammut, Robert F Storey
Blood
|
December 10, 2016
Ticagrelor: agonising over its mechanisms of action
William A E Parker, Robert F Storey
Nature Reviews. Cardiology
|
October 13, 2025
AQUATIC findings sink antiplatelet therapy for patients with chronic coronary syndrome requiring oral anticoagulants
William A E Parker, Robert F Storey
Heart (British Cardiac Society)
|
February 10, 2016
Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54
William A E Parker, Robert F Storey
Circulation
|
September 14, 2016
Choices for Potent Platelet Inhibition in Patients With Diabetes Mellitus
Robert F Storey, William A E Parker
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 3, 2024
Dapagliflozin in patients with myocardial infarction without diabetes or prior heart failure
Stefan James, Robert F Storey, Jonas Oldgren
JACC. Basic to Translational Science
|
March 29, 2021
Platelets and the Endothelium: Active Participants in Severe COVID-19 Infection
William A E Parker, Robert F Storey
Journal of the American College of Cardiology
|
May 10, 2023
Thrombotic Coronary Occlusion and Reperfusion: Unraveling the Determinants
Robert F Storey, William A E Parker
Expert Opinion on Emerging Drugs
|
February 18, 2020
Pharmacology and potential role of selatogrel, a subcutaneous platelet P2Y<sub>12</sub> receptor antagonist
William A E Parker, Robert F Storey
Journal of the American College of Cardiology
|
January 25, 2020
Opiates and Clopidogrel Efficacy: Lost in Transit?
Robert F Storey, William A E Parker
Page
of 41
Search research articles
Search
Showing results (31-40 of 401) with videos related to
Sort By:
Page
of 41
Expert Review of Cardiovascular Therapy
|
October 21, 2024
Antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary intervention
Mark Anthony Sammut, Robert F Storey
Blood
|
December 10, 2016
Ticagrelor: agonising over its mechanisms of action
William A E Parker, Robert F Storey
Nature Reviews. Cardiology
|
October 13, 2025
AQUATIC findings sink antiplatelet therapy for patients with chronic coronary syndrome requiring oral anticoagulants
William A E Parker, Robert F Storey
Heart (British Cardiac Society)
|
February 10, 2016
Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54
William A E Parker, Robert F Storey
Circulation
|
September 14, 2016
Choices for Potent Platelet Inhibition in Patients With Diabetes Mellitus
Robert F Storey, William A E Parker
European Heart Journal. Cardiovascular Pharmacotherapy
|
January 3, 2024
Dapagliflozin in patients with myocardial infarction without diabetes or prior heart failure
Stefan James, Robert F Storey, Jonas Oldgren
JACC. Basic to Translational Science
|
March 29, 2021
Platelets and the Endothelium: Active Participants in Severe COVID-19 Infection
William A E Parker, Robert F Storey
Journal of the American College of Cardiology
|
May 10, 2023
Thrombotic Coronary Occlusion and Reperfusion: Unraveling the Determinants
Robert F Storey, William A E Parker
Expert Opinion on Emerging Drugs
|
February 18, 2020
Pharmacology and potential role of selatogrel, a subcutaneous platelet P2Y<sub>12</sub> receptor antagonist
William A E Parker, Robert F Storey
Journal of the American College of Cardiology
|
January 25, 2020
Opiates and Clopidogrel Efficacy: Lost in Transit?
Robert F Storey, William A E Parker
Page
of 41